The Latest Breaking News from Morgan Stanley

The mystery of how quantitative tightening will affect markets

Central banks are starting to shrink their balance sheets, but fund managers say they have no clue as to how QT will play out

Financial Times · Jul 11, 2022

Benzinga's Top Ratings Upgrades, Downgrades For July 8, 2022

 

Benzinga · Jul 8, 2022

Morgan Stanley Maintains Overweight Rating for Cushman & Wakefield: Here's What You Need To Know

Morgan Stanley has decided to maintain its Overweight rating of Cushman & Wakefield (NYSE:CWK) and lower its price target from $21.00 to $19.00. Shares of Cushman & Wakefield are trading down 5.18% over the last 24 hours, at $14.97 per share.

Benzinga · Jul 6, 2022

Peering Into Morgan Stanley's Recent Short Interest

Morgan Stanley's (NYSE:MS) short percent of float has fallen 16.56% since its last report. The company recently reported that it has 17.98 million shares sold short, which is 1.31% of all regular shares that are available for trading.

Benzinga · Jul 5, 2022

3 Giants Jim Cramer is Betting on

Despite the recent macroeconomic headwinds and market volatility, renowned TV personality and investor Jim Cramer has placed his bets on some beaten-down shares of some industry giants because they are currently trading at attractive price levels. Wall Street analysts expect Jim Cramer’s top stock picks, Morgan Stanley (MS), The Walt…

StockNews.com · Jul 4, 2022

Tech firm that works for NHS, Morgan Stanley and RBS opens new Edinburgh office

Opencast says many of its team now work in or close to the city

Insider UK · Jul 4, 2022

Morgan Stanley Maintains Equal-Weight Rating for Haemonetics: Here's What You Need To Know

Morgan Stanley has decided to maintain its Equal-Weight rating of Haemonetics (NYSE:HAE) and raise its price target from $60.00 to $70.00. Shares of Haemonetics are trading up 1.46% over the last 24 hours, at $66.13 per share. A move to $70.00 would account for a 5.85% increase from the current…

Benzinga · Jul 1, 2022

Here's How Much $100 Invested In Morgan Stanley 10 Years Ago Would Be Worth Today

Morgan Stanley (NYSE:MS) has outperformed the market over the past 10 years by 7.36% on an annualized basis producing an average annual return of 18.05%. Currently, Morgan Stanley has a market capitalization of $133.32 billion.

Benzinga · Jun 30, 2022

What Are Whales Doing With Walgreens Boots Alliance

A whale with a lot of money to spend has taken a noticeably bullish stance on Walgreens Boots Alliance. Looking at options history for Walgreens Boots Alliance (NASDAQ:WBA) we detected 10 strange trades.

Benzinga · Jun 30, 2022

Morgan Stanley Maintains Equal-Weight Rating for Fidelity National Info: Here's What You Need To Know

Morgan Stanley has decided to maintain its Equal-Weight rating of Fidelity National Info (NYSE:FIS) and lower its price target from $102.00 to $100.00. Shares of Fidelity National Info are trading down 2.27% over the last 24 hours, at $92.42 per share.

Benzinga · Jun 30, 2022